Insiders who have reported open-market trades at the same companies as Marlene Debel. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Bill Pappas - $2.09M in MET purchases and sales on record
Michel Khalaf - $1.73M in MET purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Marlene Debel is a corporate insider, tracked as EVP & Chief Risk Officer of METLIFE INC (MET). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Marlene Debel submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Marlene Debel been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($3.63M) across all tracked filings.
Marlene Debel is EVP & Chief Risk Officer of METLIFE INC (MET). 6 SEC Form 4 filings on record going back to 2024, most recently on 2 September 2026. Most recent open-market trade: sold $1.74M of MET on 3 June 2026. Lifetime open-market sales: $3.63M.
Recent transactions
12
The latest 12 SEC Form 4 transactions reported by Marlene Debel.
InsiderAlpha's records for Marlene Debel go back to 2024: 6 primary Form 4 filings, an average of 2.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
